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The susceptibility of different populations to the SARS-CoV-2 infection is not yet understood. A 
deeper analysis of the genomes of individuals from different populations might explain their risk 
for infection. In this study, a combined analysis of ACE2 coding variants in different populations 
and computational chemistry calculations are conducted in order to probe the potential effects of 
ACE2 coding variants on SARS-CoV-2/ACE2 binding affinity. Our study reveals novel 
interaction data on the variants and SARS-CoV-2. We could show that ACE2-K26R; which is 
more frequent in the Ashkenazi Jewish population decrease the electrostatic attraction between 
SARS-CoV-2 and ACE2. On the contrary, ACE2-I468V, R219C, K341R, D206G, G211R were 
found to increase the electrostatic attraction and increase the binding to SARS-CoV-2; ordered by 
the strength of binding from weakest to strongest. I468V, R219C, K341R, D206G and G211R 
were more frequent in East Asian, South Asian, African and African American, European and 
European and South Asian populations, respectively. SARS-CoV-2/ACE2 interface in the WT 
protein and corresponding variants is showed to be a dominated by van der Waals (vdW) 
interactions. All the mutations except K341R induce an increase in the vdW attractions between 









Despite numerous reports on the clinical manifestation of the recent novel coronavirus disease 
2019 (COVID-19), including pathogenicity, diagnosis, and recommended treatment regimes, 
understanding of the mechanisms of infection, the virus-host interactions, and transmission is still 
in its early stage1–4. The risk of certain populations for the infection is also still not well understood 
and remains under investigation. After the identification of the angiotensin-converting enzyme 2 
(ACE2) as the SARS-CoV-2 receptor5, a large number of reports have emerged trying to identify 
the pathology of the disease, and thus provide guidance to the efforts to design small molecules 
inhibitors3,5. Some recent studies attempted to probe the comorbidity among infected patients, 
specifically patients with hypertension, diabetes mellitus, coronary heart diseases, and 
cerebrovascular disease that showed increased risk. Whether ACE2 polymorphisms linked to the 
aforementioned diseases or administration of ACE2 modulating drugs have larger impact on the 
severity of infection is still a question to be investigated6.  
 
Communications between the pathogen and the host is mainly governed by the different protein-
protein electrostatic interactions7,8. These proteins need to bind in a specific way for protein-
protein complexes formation and for the signals to be effectively transmitted. The existence of 
residues that are involved in energetically favorable interactions at the protein-protein interface 
leads to enhanced interactions leading to viral-host cells fusion, marking the onset of the 
infection5,9. Therefore, we opted herein to investigate the nature of the interactions at the SARS-
CoV-2/ACE2 interface, and how the subtle variations in the structure of ACE2, induced by certain 
mutations, can alter the binding of SARS-CoV-2 in different populations. This was attempted here 
by analyzing different ACE2 missense variants that code for ACE2-K26R, ACE2-I468V, ACE2-
R219C, ACE2-K341R, ACE2-D206G, ACE2-G211R and the strength of their interaction with the 
spike protein (S-protein) of SARS-COV-2 using Molecular Dynamics and Monte Carlo Sampling, 
which are dominated by electrostatics. The electrostatics interactions are the dominant factor in 
protein-protein interactions10, where classical treatment of these interactions in solution are 
described by the Poisson-Boltzmann equation (PBE). 
 
Our data demonstrates an increase in the strength of the binding of the variants; in the order 
mentioned, with K26R showing the least favorable binding and G211R showing the most 
favorable binding. We analyzed the frequencies of the alleles in different populations to identify 
the population in which each variant is more frequent. Our data help in identifying variations of 
appreciable frequencies and the implications for each in affecting the strength of the virus-receptor 
interactions in individuals of different populations. 
 
Materials and methods: 
 
Classical electrostatic calculations based on solving Poisson-Boltzmann (PB) equation is used to 
investigate the interaction energies between SARS-CoV-2 and ACE2 for different mutated ACE2 
structures. All continuum electrostatics calculations were performed by the freely available 
software “Multi-Conformer Continuum electrostatics (MCCE)”11. Where that interaction energies 
are modeled by treating each residue as separate fragments with integer charges, which are 
interacting with each other by means of electrostatic and Lennard-Jones potentials11. The Poisson-
Boltzmann (PB) equation is numerically solved by DELPHI software, which is integrated within 
the MCCE code, to compute self-energies of each conformer and pair-wise interaction energies 
between conformers and between conformers and backbone. Upon energy calculations, the energy 
look-up table is built, and theoretical titration is modeled by obtaining Boltzmann distribution of 
microstates, using the Monte-Carlo approach. Where that microstates of the structures are defined 
depending on rotamers and protonation states of the different amino acids. Where that the protein 
interior are considered as highly polar media with low dielectric constant (𝜀!"#$	 = 4),  whereas 
the solvent (water) is treated as a continuum medium with high dielectric constant (𝜀&'$ = 	80).  
 
Initial coordinates are defined according to the X-ray crystal structure of the wild type (WT) human 
ACE2 with the receptor-binding domain RDB of the S protein of SARS-CoV-2 (PDB ID: 6M17) 
from the protein data bank5. The structure of the Neutral amino acid transporter B0AT1 was 
removed from the PDB file, as it is far from the SARS-CoV-2/ACE2 binding site. Furthermore, 
the structure of ACE2 was trimmed by removing residues from P733 to the end of the chain. The 
WT residues of ACE2 at positions 26, 206, 211, 219, 341 and 468 were mutated to Arg (R), Gly 
(G), Arg (R), Cys (C), Arg (R) and Val (V), respectively. The sidechains in the WT structure was 
replaced with the sidechains of the mutants using MCCE (Multi Conformer Continuum 
Electrostatics) (Fig. 1). A set of different conformers of the sidechains were generated for WT and 
mutated structures by rotating the single bonds in the sidechains by 600 degrees. In addition, 
conformers were created for charged amino acids according to their possible protonation states. 
Then, these conformers were subjected to Monte Carlo sampling to obtain the Boltzmann 
distribution based on the electrostatic interactions, which are calculated using DELPHI. The most 
occupied conformers in the generated Boltzmann distributions were selected and subjected to 
molecular dynamics optimization using openMM. Finally, the interaction energies were computed 
for the optimized structures using MCCE. The electrostatics and van der Waals interactions 




Results and discussion: 
In an attempt to better understand the susceptibility of different populations to infection by SARS-
CoV-2, we gathered data on ACE2 missense variants from different projects and databases that 
aggregate allele frequencies (AF). These projects and databases included Single Nucleotide 
Polymorphism Database (dbSNP)12,13, 1000 genomes project phase 3 (1KGP3)14, Allele 
Frequency Aggregator (ALFA project)a, Exome Aggregation Consortium (ExAC)15,genome 
Aggregation Database (gnomAD)b,16, GO exome sequencing project (ESP)c, Trans-Omics for 
Precision Medicine (TopMed)17, in addition to a recent study reporting data from the China 
Metabolic Analytics Project (ChinaMAP, under reviewing) and other populations18.   
 
SARS-CoV-2 was reported to bind to human ACE2 via different ACE2 residues; Q24, D30, H34, 
Y41, Q42, M82, K353 and R3575. We analyzed all ACE2 coding variants reported and selected 
the variants that are close to the interaction site to test for changes in their binding interactions to 
SARS-CoV-2. To focus on the most frequent variants, we did not include variants of very low 
allele count in all populations. The variants we tested were K26R, D206G, G211R, R219C, K341R 
and I468V. Table S1 shows the frequency of each allele in the African, African American, 
American, Ashkenazi Jewish, Asian (All, ChinaMAP, East Asian, Han Chinese South, Han 
Chinese Beijing and South Asian), European (All, European American, Finnish and non-Finnish) 
and Latino. 
 
Variations in ACE2 affect its interaction with SARS-CoV-2 
The electrostatic and the van der Waal contribution to the interaction energies of SARS-CoV-
2/ACE2 were compared between single mutated and WT protein at pH =7 (Table 1). In contrary 
to K26R, most of the mutated structures exhibit a negative shift in the total interaction energy 
compared to the WT structure (Native) i.e. more electrostatic attraction with the spike protein of 
SARS-CoV-2. Based on our calculations, G211R mutant is shown to induce the largest increase 
in the binding energy between SARS-CoV-2 and ACE2, where the binding is more favorable by 
~ 7.6 Kcal/mol than the WT. However, the K26R mutant causes a decrease in the binding energies 
by ~ 2.1 Kcal/mol (Table 1). 
 
Figure 1. The secondary structure of the ACE2 protein (shown in orange) and the RBD of 
the SARS-CoV-2 (shown in blue). The mutated amino acids are shown in magenta spheres 
(6M17)5.  
 
The substitution of Lys (K) to Arg (R) at positions 211 and 341 was shown to increase the 
electrostatic attraction between SARS-CoV-2 and ACE2 by 1.29-fold and 1.47-fold in comparison 
to the WT, respectively. Oppositely, substitution of R at position 26 was shown to reduce the 
electrostatic attraction between SARS-CoV-2 and ACE2 to 2.59 Kcal/mol lower than that in WT. 
In addition, the D206G mutant showed similar electrostatic interactions to the WT. However, the 
R219C, I468V mutants showed significant decrease in the electrostatic attraction to by ~5 
Kcal/mol compared to the WT (Table 1). SARS-CoV-2/ACE2 interface in the WT protein and 
corresponding mutants is showed to be a dominated by vdW interactions, which accounts for more 
than 60% of the interaction energy. All the mutations except K341R induced an increase in the 
vdW attractions between the ACE2 and the SARS-CoV-2. The largest increase of ~ 8 Kcal/mol is 
observed for the R219C mutant (Table 1). 
 
Our results, shown in Fig. 2, demonstrate large variations in calculated binding energy in different 
ACE2 variants (identified in the table 1) towards SARS-CoV-2 S protein. Although the calculated 
variations in binding energies are appreciable, as compared to the control, we hypothesize that 
even within the same population mutations in ACE2 in certain individuals can similarly 
dramatically influence the binding site configuration and ACE2/SARS-CoV-2 binding affinity. 
 








G211R -12.4 -35.4 -47.8 European 
South Asian 
D206G -8.8 -36.1 -44.9 European 
K341R -14.2 -29.3 -43.4 African/African 
American 
R219C -4.6 -38.3 -42.9 South Asian 
I468V -4.7 -37.4 -42.1 East Asian 
Native -9.6 -30.1 -40.2  
K26R -3.7 -34.4 -38.1 Ashkenazi 
Jewish 





Figure. 2. Representation of Binding energies calculated in Table 1 and the corresponding 
population with the highest allele frequency. 
 
 
How ACE2 variants can impact the susceptibility of different population to SARS-CoV-2 
infection? 
 
The K26R variant which decreases the ACE2-virus binding was found to be most frequent in the 
Ashkenazi Jewish population (1.2%). On the contrary, the Asian population had the lowest allele 
frequency for the single nucleotide variant (SNV) coding for K26R. In addition, the frequency of 
I468V which enhance ACE2 interaction with SARS-CoV-2 was observed in more than 1% of the 
East Asian population. Interestingly, I468V was not detected in the African, African American, 
American, Ashkenazi Jewish and Latino populations and was very rare in the European population. 
R219C was most frequent in the south Asian population (0.1%), but was not detected in other 
Asian subpopulations and was much less frequent or lacking in other populations. The K341R, 
which enhance the virus-receptor binding was most frequent in the African and African American 
populations; the average of the AF reported for the populations was ~ 0.4% and ~ 0.5%, 
respectively. Finally, the D206G and G211R, which showed the strongest interaction with ACE2 
were most abundant in the European population, mounting to 0.06% and ~ 0.2%, respectively. The 
G211R was also abundant in the South Asian population ~ 0.2%. 
 
Our findings give indications regarding the populations that could be more prone to SARS-CoV-
2 infection due to enhanced binding affinity. Nevertheless, the need for proper infection, death and 
recovery statistics is needed to reach a definite conclusion. K26R and I468V are considered of 
intermediate frequencies (>1%) in the Ashkenazi Jewish and East Asian population, respectively. 
Therefore, we would refer to them as Single Nucleotide Polymorphism (SNPs) in the respective 
populations. However, the other variants are considered of rare frequencies (<1%)19,20. 
Nevertheless, in the era of Individualized Genomics, the individual differences in the same 
population should also be taken into account as rare variants might exist affecting the virus binding 
to ACE2 in many individuals.  
 
The possibility of having individuals baring more than one of the mutations that enhance the 
binding is also still an open question, that will be answered via sequencing of ACE2 in more 
individuals of the aforementioned populations. The presence of variants for the serine protease 
TMPRSS2; required for S protein priming, in different populations could also account for 
differences in viral entry and pathogenesis9. 
 
Conclusion 
Our data suggests that certain populations might be more affected by SARS-CoV-2; depending on 
the frequency of the respective variants. To better understand the susceptibility of individuals from 
different populations to SARS-CoV-2 and their risk of infection, large scale sequencing projects 
should be performed. Integrating population genetics will provide a new insight into the mystery 
of susceptibility, infection, pathogenicity and mortality in different regions. Sequencing of ACE2 
in patients with the most severe conditions in every population will also provide a more reliable 
conclusion. The sequencing projects will not only help us test the association between ACE2 
variants and risk/severity of infection in certain populations, it will also allow more accurate 
analysis of variants for other host genes involved in the viral entry and pathogenicity21. Finally, 
our findings can potentially guide future attempts to devise small molecules inhibitors, designed 
specifically to disrupt the interaction between the strongest ACE2 binding variants and the S 
protein of SARS-CoV-22. 
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